These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 23837450

  • 21. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
    Bhavsar NA, Köttgen A, Coresh J, Astor BC.
    Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
    [Abstract] [Full Text] [Related]

  • 22. Novel urinary biomarkers in detecting acute kidney injury, persistent renal impairment, and all-cause mortality following decongestive therapy in acute decompensated heart failure.
    Verbrugge FH, Dupont M, Shao Z, Shrestha K, Singh D, Finucan M, Mullens W, Tang WH.
    J Card Fail; 2013 Sep; 19(9):621-8. PubMed ID: 24054338
    [Abstract] [Full Text] [Related]

  • 23. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy.
    Liu LL, Jiang Y, Wang LN, Liu N.
    Clin Exp Immunol; 2012 Aug; 169(2):148-55. PubMed ID: 22774989
    [Abstract] [Full Text] [Related]

  • 24. The utility of kidney injury molecule-1 as an early biomarker of kidney injury in people living with HIV.
    Danjuma MI, Al Shokri S, Bakhsh N, Alamin MA, Mohamedali MG, Tamuno I.
    Int J STD AIDS; 2020 Nov; 31(13):1228-1237. PubMed ID: 32951563
    [Abstract] [Full Text] [Related]

  • 25. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy.
    Ding H, He Y, Li K, Yang J, Li X, Lu R, Gao W.
    Clin Immunol; 2007 May; 123(2):227-34. PubMed ID: 17360238
    [Abstract] [Full Text] [Related]

  • 26. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
    Zittema D, van den Brand JA, Bakker SJ, Wetzels JF, Gansevoort RT.
    Nephrol Dial Transplant; 2017 Jan 01; 32(suppl_1):i146-i153. PubMed ID: 28057871
    [Abstract] [Full Text] [Related]

  • 27. Assessment of urinary kidney injury molecule-1 and interleukin-18 in the early post-burn period to predict acute kidney injury for various degrees of burn injury.
    Ren H, Zhou X, Dai D, Liu X, Wang L, Zhou Y, Luo X, Cai Q.
    BMC Nephrol; 2015 Aug 18; 16():142. PubMed ID: 26283194
    [Abstract] [Full Text] [Related]

  • 28. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    BMC Nephrol; 2017 Mar 14; 18(1):89. PubMed ID: 28292274
    [Abstract] [Full Text] [Related]

  • 29. Urinary exosomal mRNAs as biomarkers for predicting the therapeutic effect of renin-angiotensin system inhibitors in IgA nephropathy patients.
    Zhao B, Wang M, Cong Y, Song A, Lu J, Xie K, Dai H, Gu L.
    Clin Chim Acta; 2024 Jul 15; 561():119750. PubMed ID: 38885756
    [Abstract] [Full Text] [Related]

  • 30. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
    Fu WJ, Xiong SL, Fang YG, Wen S, Chen ML, Deng RT, Zheng L, Wang SB, Pen LF, Wang Q.
    Endocrine; 2012 Feb 15; 41(1):82-8. PubMed ID: 21779943
    [Abstract] [Full Text] [Related]

  • 31. Kidney injury molecule-1 correlates with kidney function in heart allograft recipients.
    Przybylowski P, Malyszko J, Kozlowska S, Malyszko JS.
    Transplant Proc; 2011 Oct 15; 43(8):3061-3. PubMed ID: 21996225
    [Abstract] [Full Text] [Related]

  • 32. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.
    Clin Nephrol; 2003 Nov 15; 60(5):318-26. PubMed ID: 14640237
    [Abstract] [Full Text] [Related]

  • 33. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
    Peters HP, van den Brand JA, Wetzels JF.
    Neth J Med; 2009 Feb 15; 67(2):54-61. PubMed ID: 19299847
    [Abstract] [Full Text] [Related]

  • 34. Kidney injury molecule (KIM)-1 is associated with insulin resistance: results from two community-based studies of elderly individuals.
    Carlsson AC, Calamia M, Risérus U, Larsson A, Helmersson-Karlqvist J, Lind L, Arnlöv J.
    Diabetes Res Clin Pract; 2014 Mar 15; 103(3):516-21. PubMed ID: 24438875
    [Abstract] [Full Text] [Related]

  • 35. The product of duration and amount of proteinuria (proteinuria index) is a possible marker for glomerular and tubulointerstitial damage in IgA nephropathy.
    Eiro M, Katoh T, Kuriki M, Asano K, Watanabe K, Watanabe T.
    Nephron; 2002 Apr 15; 90(4):432-41. PubMed ID: 11961402
    [Abstract] [Full Text] [Related]

  • 36. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
    Gong WY, Liu M, Luo D, Liu FN, Yin LH, Li YQ, Zhang J, Peng H.
    BMC Nephrol; 2019 Apr 30; 20(1):150. PubMed ID: 31039758
    [Abstract] [Full Text] [Related]

  • 37. Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.
    Hogg RJ, Bay RC, Jennette JC, Sibley R, Kumar S, Fervenza FC, Appel G, Cattran D, Fischer D, Hurley RM, Cerda J, Carter B, Jung B, Hernandez G, Gipson D, Wyatt RJ.
    Am J Kidney Dis; 2015 Nov 30; 66(5):783-91. PubMed ID: 26209543
    [Abstract] [Full Text] [Related]

  • 38. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
    Suzuki H, Allegri L, Suzuki Y, Hall S, Moldoveanu Z, Wyatt RJ, Novak J, Julian BA.
    Dis Markers; 2016 Nov 30; 2016():7806438. PubMed ID: 27647947
    [Abstract] [Full Text] [Related]

  • 39. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
    Asao R, Asanuma K, Kodama F, Akiba-Takagi M, Nagai-Hosoe Y, Seki T, Takeda Y, Ohsawa I, Mano S, Matsuoka K, Kurosawa H, Ogasawara S, Hirayama Y, Sekine S, Horikoshi S, Hara M, Tomino Y.
    Clin J Am Soc Nephrol; 2012 Sep 30; 7(9):1385-93. PubMed ID: 22700887
    [Abstract] [Full Text] [Related]

  • 40. Proteinuria in the prognosis of IgA nephropathy.
    Aucella F, Netti GS, Piemontese M, Cincione IR, Infante B, Gesualdo L.
    Minerva Urol Nefrol; 2009 Sep 30; 61(3):235-48. PubMed ID: 19773725
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.